FIG 1. MTR histograms of the NABT of patients with CIS at presentation who developed CDMS during the follow-up period (continuous line) and of patients with CIS at presentation who did not develop CDMS during the follow-up period (dotted line)
FIG 1. MTR histograms of the NABT of patients with CIS at presentation who developed CDMS during the follow-up period (continuous line) and of patients with CIS at presentation who did not develop CDMS during the follow-up period (dotted line)